NIFEREX- ferrous asparto glycinate, iron, ascorbic acid, folic acid, cyanocobalamin, zinc, succinic acid, and intrinsic factor tablet

국가: 미국

언어: 영어

출처: NLM (National Library of Medicine)

유효 성분:

FERROUS ASPARTO GLYCINATE (UNII: H7426RGB3L) (FERROUS CATION - UNII:GW89581OWR), IRON DEXTRAN (UNII: 95HR524N2M) (FERRIC CATION - UNII:91O4LML611), ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R), LEVOMEFOLIC ACID (UNII: 8S95DH25XC) (LEVOMEFOLIC ACID - UNII:8S95DH25XC), FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8), CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204), ZINC (UNII: J41CSQ7QDS) (ZINC - UNII:J41CSQ7QDS), SUCCINIC ACID (UNII: AB6MNQ6J6L) (SUCCINIC ACID - UNII:AB6MNQ6J6L), INTRINSIC FACTOR (UNII: 70BT6OQT2Q) (INTRINSIC FACTOR - UNII:70BT6OQT2Q)

제공처:

Avion Pharmaceuticals, LLC

INN (국제 이름):

FERROUS ASPARTO GLYCINATE

구성:

FERROUS CATION 50 mg

관리 경로:

ORAL

처방전 유형:

PRESCRIPTION DRUG

치료 징후:

INDICATIONS: Niferex™ is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency. CONTRAINDICATIONS : Niferex™ is contraindicated in patients with a known hypersensitivity to any of the ingredients.

제품 요약:

HOW SUPPLIED: Bottles of 30 tablets (75854-321-30). The listed product number is not a National Drug Code. Instead, Avion Pharmaceuticals has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems.

승인 상태:

unapproved drug other

제품 특성 요약

NIFEREX- FERROUS ASPARTO GLYCINATE, IRON, ASCORBIC ACID, FOLIC ACID,
CYANOCOBALAMIN, ZINC, SUCCINIC ACID, AND INTRINSIC FACTOR TABLET
AVION PHARMACEUTICALS, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
IRON SUPPLEMENT
NIFEREX
 TABLETS
RX ONLY DIETARY SUPPLEMENT
RX ONLY DIETARY SUPPLEMENT
DESCRIPTION: Niferex™ for oral administrationis a prenatal/postnatal
iron supplement
that is a round, copper colored tablet with "NxFE" embossed on one
side.
OTHER INGREDIENTS: Croscarmellose sodium, dicalcium phosphate,
magnesium
stearate, microcrystalline cellulose, silicon dioxide, stearic acid.
Coating contains: HPMC,
triacetin, titanium dioxide, Candurin® Orange (FD&C Blue #1, FD&C Red
#40, FD&C
Yellow #6). THIS PRODUCT CONTAINS FD&C YELLOW #6.
TM
INDICATIONS: Niferex™ is a multivitamin/multimineral dietary
supplement indicated for
use in improving the nutritional status of patients with iron
deficiency.
CONTRAINDICATIONS: Niferex™ is contraindicated in patients with a
known
hypersensitivity to any of the ingredients.
PRECAUTIONS: Folic acid alone is improper therapy in the treatment of
pernicious
anemia and other megaloblastic anemias where Vitamin B12 is deficient.
Folic acid in
doses above 1.0 mg daily may obscure pernicious anemia in that
hematologic remission
can occur while neurological manifestations progress.
WARNING: Accidental overdose of iron-containing products is a leading
cause of
fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF
CHILDREN. In case of accidental overdose, call a doctor or poison
control center
immediately.
ADVERSE REACTIONS: Allergic sensitization has been reported following
both oral and
parenteral administration of folic acid.
DOSAGE AND ADMINISTRATION: One softgel daily, or as directed by a
physician.
HOW SUPPLIED: Bottles of 30 tablets (75854-321-30). The listed product
number is
not a National Drug Cod